Xenon Pharmaceuticals (XENE) Leases (2019 - 2025)
Historic Leases for Xenon Pharmaceuticals (XENE) over the last 7 years, with Q3 2025 value amounting to $7.0 million.
- Xenon Pharmaceuticals' Leases fell 1571.81% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year decrease of 1571.81%. This contributed to the annual value of $7.9 million for FY2024, which is 1364.08% down from last year.
- Latest data reveals that Xenon Pharmaceuticals reported Leases of $7.0 million as of Q3 2025, which was down 1571.81% from $7.3 million recorded in Q2 2025.
- Xenon Pharmaceuticals' 5-year Leases high stood at $10.4 million for Q4 2022, and its period low was $3.0 million during Q3 2021.
- In the last 5 years, Xenon Pharmaceuticals' Leases had a median value of $7.9 million in 2024 and averaged $7.6 million.
- As far as peak fluctuations go, Xenon Pharmaceuticals' Leases soared by 28533.65% in 2021, and later plummeted by 1571.81% in 2025.
- Xenon Pharmaceuticals' Leases (Quarter) stood at $8.1 million in 2021, then grew by 29.17% to $10.4 million in 2022, then fell by 11.66% to $9.2 million in 2023, then dropped by 13.64% to $7.9 million in 2024, then decreased by 12.33% to $7.0 million in 2025.
- Its Leases stands at $7.0 million for Q3 2025, versus $7.3 million for Q2 2025 and $7.6 million for Q1 2025.